仿制药价格飙升：美国食品药品监督管理局正努力加以控制。
Generic prices take flight: the FDA is struggling to ground them.
作者信息
Barlas Stephen
出版信息
P T. 2014 Dec;39(12):833-45.
Abstract
The prices of some generic pharmaceuticals have lifted off into the stratosphere. A variety of reasons account for the increases, including loss of competition, dropping of product lines, and delays at the Food and Drug Administration.
摘要
一些非专利药品的价格已经飙升至天价。价格上涨有多种原因，包括竞争缺失、产品线停产以及美国食品药品监督管理局的审批延迟。
相似文献
1
Generic prices take flight: the FDA is struggling to ground them.仿制药价格飙升：美国食品药品监督管理局正努力加以控制。
P T. 2014 Dec;39(12):833-45.
2
What Commissioner Gottlieb's FDA Is Doing to Lower Prescription Drug Prices and Steps Congress Can Take to Help.戈特利布专员领导的美国食品药品监督管理局（FDA）为降低处方药价格所采取的措施以及国会可采取的协助措施。
Issue Brief (Commonw Fund). 2018 Apr 1;2018:1-10.
3
Generic Drugs in the United States: Policies to Address Pricing and Competition.美国的仿制药：解决定价和竞争问题的政策。
Clin Pharmacol Ther. 2019 Feb;105(2):329-337. doi: 10.1002/cpt.1314. Epub 2019 Jan 10.
4
Projecting future drug expenditures--1992.预测未来药品支出——1992年
Am J Hosp Pharm. 1992 Jan;49(1):140-5.
5
Association Between Market Competition and Prices of Generic Topical Dermatology Drugs.市场竞争与皮肤科外用药品通用名药物价格的关联。
JAMA Dermatol. 2018 Dec 1;154(12):1441-1446. doi: 10.1001/jamadermatol.2018.3798.
6
OSTEOPOROSIS DRUGS MARKETED IN THE UNITED STATES: GENERIC COMPETITION, PRICING STRUCTURE, AND DISPERSION AMONG PAYERS.在美国销售的骨质疏松症药物：仿制药竞争、定价结构及支付方之间的差异
Int J Technol Assess Health Care. 2016 Jan;32(6):385-392. doi: 10.1017/S0266462316000623. Epub 2017 Jan 9.
7
Scott Gottlieb Believes a Nimbler, Speedier FDA Can Spur Competition, Lower Prices.斯科特·戈特利布认为，一个更灵活、行动更迅速的美国食品药品监督管理局（FDA）能够促进竞争、降低价格。
Manag Care. 2017 Aug;26(8):16-18.
8
Does generic entry lower the prices paid for pharmaceuticals in Australia? A comparison before and after the introduction of the mandatory price-reduction policy.非专利药进入市场是否降低了澳大利亚药品的购买价格？对强制降价政策实施前后的比较。
Aust Health Rev. 2013 Nov;37(5):675-81. doi: 10.1071/AH13024.
9
The effect of generic competition on the price of brand-name drugs.仿制药竞争对品牌药价格的影响。
Health Policy. 2004 Apr;68(1):47-54. doi: 10.1016/j.healthpol.2003.07.007.
10
Costs of paying higher prices for equivalent effects on the Pharmaceutical Benefits Scheme.在药品福利计划中为同等效果支付更高价格的成本。
Aust Health Rev. 2017 Mar;41(1):1-6. doi: 10.1071/AH15122.
引用本文的文献
1
Biomedical and Market Issues Surrounding the Advent of Biosimilars.围绕生物类似药问世的生物医学与市场问题。
Dermatol Ther (Heidelb). 2016 Sep;6(3):341-5. doi: 10.1007/s13555-016-0127-4. Epub 2016 Jun 21.
Zotero 插件